A 67-year-old man with heart failure with reduced ejection fraction (EF 30%) remains symptomatic (NYHA II-III) despite optimal doses of an ACE inhibit...

Question

A 67-year-old man with heart failure with reduced ejection fraction (EF 30%) remains symptomatic (NYHA II-III) despite optimal doses of an ACE inhibitor and evidence-based beta blocker. According to the CCS heart failure guideline, which additional medication class should be part of his core foundational regimen if no contraindications exist?

Accepted Answer

Mineralocorticoid receptor antagonist

Answer

Short-acting nitrate as regular therapy

Answer

Ivabradine

Answer

Loop diuretic at fixed high dose

Answer

Digoxin as routine therapy

ca-mccqe1 MCQ (SBA): Heart failure with reduced ejection fraction